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Our laboratory has been utilizing mouse models of obesity to understand the relationship between obesity and asthma. We have reported that in the absence of any inciting stimulus, airway hyperresponsiveness (AHR) to intravenously administered bronchoconstrictors is observed in mice obese as a result of a genetic deficiency in leptin, a satiety hormone (ob/ob mice) (27, 45, 50) , or the long form of the leptin receptor (db/db mice) (36, 52) ; in mice obese due to a genetic deficiency in carboxypeptidase E (Cpe) (25) , an enzyme involved in processing prohormones and proneuropeptides involved in satiety and energy expenditure (Cpe fat mice); and in mice obese due to the consumption of a high-fat diet (24) . We have also shown that acute exposure to O 3 augments airway responsiveness, pulmonary injury, and pulmonary inflammation to a greater extent in obese compared with lean mice (24, 25, 32, 36, 45, 50, 52) . Thus obese mice manifest many of the characteristic features of asthma, including AHR to nonspecific bronchoconstrictors and enhanced pulmonary responses to O 3 , and may serve as useful tools to enhance our understanding of the relationship between obesity and asthma.
Besides being a major storage depot for lipids, adipose tissue is now recognized as an important endocrine organ that synthesizes many hormones, including leptin, adiponectin, and resistin (39) . In obesity, adipose tissue becomes infiltrated with macrophages and also synthesizes acute-phase proteins, cytokines, chemokines, and soluble cytokine receptors, including IL-6, monocyte chemotactic protein (MCP)-1, plasminogen activator inhibitor (PAI)-1, and TNF-␣ (6, 39, 46, 59, 60) . These substances, collectively termed adipokines, are largely proinflammatory in nature and once released into the systemic circulation result in a condition commonly referred to as chronic systemic inflammation. Importantly, the levels of some of these adipokines correlate directly with the severity of obesity-related diseases, such as atherosclerosis and insulin resistance (5, 46, 54) . For example, insulin resistance is associated with increased adipose tissue expression of IL-6, but decreased expression of adiponectin, an insulin-sensitizing adipokine (63) . In addition, obese mice genetically deficient in some of these proinflammatory adipokines, such as MCP-1 and TNF-␣, are protected from obesity-related diseases (28, 57) . In mice, the onset of obesity-induced insulin resistance is observed only once increased inflammatory gene expression in the adipose tissue has been established (62) .
Hence, the purpose of this study was to determine if the enhanced airway responsiveness to bronchoconstrictors and the increased responsiveness to O 3 , observed in obese mice, correlated temporally with the onset of systemic inflammation during the onset of obesity. To do so, we measured systemic markers of inflammation, airway responsiveness to intravenous methacholine, and pulmonary injury and inflammation induced by acute O 3 exposure in 7-and 10-wk-old Cpe fat and wild-type, C57BL/6 control mice. Our data indicate a temporal dissociation between the innate AHR and the increased responses to O 3 observed in obese mice, indicating that the mechanistic bases for these phenomena are not the same.
MATERIALS AND METHODS
Animals. These studies were approved by the Harvard Medical Area Standing Committee on Animals. Male and female homozygous Cpe fat mice were purchased at 6 wk of age from The Jackson Laboratory (Bar Harbor, ME) or born in a rodent barrier facility at the Harvard School of Public Health in Boston, MA, from breeding pairs of heterozygous Cpe fat mice, which were also purchased from The Jackson Laboratory. Since the Cpe fat mice used in this study were backcrossed onto a C57BL/6J background for at least 10 generations, age-and sex-matched wild-type, C57BL/6J mice were purchased from The Jackson Laboratory at the same time and used as controls. Within each age cohort, the distribution of sexes was matched across obesity groups. The percentage of male mice was 45% and 40% among the 7-wk-old wild-type and Cpe fat mice, respectively, and 32% and 27% for the 10-wk-old wild-type and Cpe fat mice, respectively. Protocol. Two cohorts each of 7-and 10-wk-old wild-type, C57BL/6 and Cpe fat mice were used in this study. In the first cohort of mice, the animals were anesthetized and instrumented for the measurement of baseline pulmonary mechanics and airway responsiveness to methacholine (Sigma-Aldrich; St. Louis, MO). In the second cohort of 7-and 10-wk-old mice, the animals were euthanized, blood was collected, and a bronchoalveolar lavage (BAL) was performed 4 h following the cessation of a 3-h exposure to either O 3 (2 ppm) or room air. We chose to examine the animals 4 h following the cessation of exposure because we have previously reported that this O 3 exposure regimen significantly elevates the BAL fluid (BALF) concentrations of many inflammatory cytokines and chemokines of interest, and because O 3-induced inflammation is increased in Cpe fat mice as well as other types of obese mice compared with lean, wild-type control mice with this exposure regimen (24, 25, 32, 36, 50, 52) .
O 3 and room air exposures. Conscious mice were placed in individual wire-mesh cages, which were subsequently placed inside a 145-liter stainless steel and Plexiglas exposure chamber where they were exposed to O 3 (2 ppm) for 3 h. Separate but identical chambers were used for 3-h, room air exposures. The O3 was generated and the concentration monitored as previously described (22) .
Measurement of baseline pulmonary mechanics and airway responsiveness to methacholine. Mice were anesthetized with intraperitoneal injections of pentobarbital sodium (50 mg/kg) and xylazine (7 mg/kg). The trachea was cannulated with a tubing adaptor, and the tail vein was cannulated for the delivery of methacholine. A wide incision in the chest wall was made bilaterally to expose the lungs to atmospheric pressure, and the wild-type and Cpe fat mice were artificially ventilated (flexiVent; SCIREQ, Montreal, Quebec, Canada) at 150 or 180 breaths/min, respectively, with a tidal volume (VT) of 0.3 ml and a positive end-expiratory pressure of 3 cmH2O. Lungs were inflated to three times VT to standardize volume history before each maneuver. Baseline pulmonary mechanics and responses to intravenous methacholine were measured using the forced oscillation technique, as described previously (45, 50) . After PBS (1 l/g) or increasing concentrations of methacholine, dissolved in PBS (1 l/g), were injected, we measured pulmonary resistance (RL), using a sinusoidal forcing function at a frequency of 2.5 Hz every eighth breath until resistance peaked. At that point, measurements of total lung impedance (ZL) were obtained using an 8-s optimized pseudorandom signal containing frequencies ranging from 0.25 to 19.63 Hz. A parameter estimation model (16) was used to partition ZL into components representing airway resistance (Raw) and the coefficients of lung tissue damping (G) and lung tissue elastance (H).
Blood collection and BAL. The animals were euthanized with an intraperitoneal injection of pentobarbital sodium, and blood was subsequently collected from the heart via cardiac puncture. The red blood cells in a 10-l aliquot of blood were lysed in a cell lysis solution, and the total number of blood leukocytes was then enumerated with a hemacytometer. In addition, serum was isolated from the blood and stored at Ϫ20°C until analyzed.
After blood was collected from each animal, a BAL was performed and the BALF cells and differentials were counted as previously described (23) . The BALF was stored at Ϫ80°C until needed. Subsequently, the total BALF protein concentration was determined spectrophotometrically according to the Bradford protein assay procedure (Bio-Rad Laboratories; Hercules, CA). The concentrations of BALF and/or serum adiponectin, eotaxin, KC, monocyte chemotactic protein (MCP)-1, macrophage inflammatory protein (MIP)-2, and soluble tumor necrosis factor receptor (sTNFR) 1 and 2 were determined by Quantikine ELISA kits or DuoSet ELISA development systems (R&D Systems; Minneapolis, MN), according to the manufacturer's instructions.
Statistical analysis of data. Comparisons of body weight and serum markers of inflammation were assessed by factorial ANOVA with genotype and age as the main effects. In the case of serum IL-6, the data were logarithmically transformed to conform to a normal distribution. Within each age group, comparisons of BALF parameters were assessed by factorial ANOVA with genotype, age, and exposure as the main effects. Fisher's least significance difference test was used as a follow-up to determine the significance of differences between the individual groups. For the analyses of BALF cells, values were logarithmically transformed to conform to a normal distribution. Within each age group, comparisons of methacholine-induced changes in pulmonary mechanics were assessed by repeated-measures ANOVA using the dose of methacholine as the repeated variable and genotype and age as the main effect. STATISTICA software (StatSoft; Tulsa, OK) was used to perform all statistical analyses. A P value Ͻ 0.05 was considered significant. All values are expressed as means Ϯ standard error of the mean (SE), unless otherwise noted.
RESULTS
Body mass. Factorial ANOVA indicated a significant effect of age and genotype on body mass in both male and female mice (P Ͻ 0.001 in each case). Regardless of age, Cpe fat mice weighed significantly more than their age-and sex-matched, wild-type controls (Fig. 1) , but the magnitude of obesity increased with age. At 7 and 10 wk of age, Cpe fat mice weighed approximately 25 and 61% more, respectively, than agematched controls.
Serum markers of inflammation. Factorial ANOVA indicated a significant (P Ͻ 0.05) effect of genotype on the levels of all systemic markers of inflammation (sTNFR1, sTNFR2, IL-6, leptin, adiponectin, and blood leukocytes) examined in the serum or blood, with the exception of MCP-1 (P ϭ 0.084). In each case, the effect lay in the 10-wk-old mice, in which levels were significantly greater in Cpe fat mice compared with age-matched controls (Fig. 2) . In 7-wk-old mice, the levels of each systemic marker of inflammation were slightly greater in Cpe fat compared with wild-type mice. However, in the 7-wk-old mice, the only outcome indicator that was significantly increased in Cpe fat vs. wild-type mice was serum leptin (Fig. 2E) . Airway responsiveness to intravenous methacholine. We have previously reported that by 14 wk of age, Cpe fat mice exhibit innate AHR (25) . To examine the onset of this phenomenon with increasing obesity, we measured changes in RL induced by intravenous methacholine in unexposed 7-and 10-wk-old Cpe fat and age-matched controls (Fig. 3, A and B) . Repeated-measures ANOVA indicated a significant (P Ͻ 0.001) effect of genotype in 10-wk-old mice, but not in 7-wk-old mice. In the 10-wk-old mice, responses to methacholine were significantly greater in the Cpe fat than the wild-type mice (Fig. 3B) . We also observed a significant (P Ͻ 0.001) interaction between methacholine dose and age in the Cpe fat mice, with greater changes in RL at 0.3 mg/ml methacholine in 10-vs. 7-wk-old Cpe fat mice. In contrast, in wild-type mice, there was no significant interaction between dose and age, and the trend was in the opposite direction (i.e., lower responses to methacholine in the older mice). To determine if changes in the airways or the lung tissues accounted for the AHR observed in 10-wk-old Cpe fat mice, we also examined methacholine-induced changes in Raw, G, and H in these animals (Fig. 4) . Methacholine caused a dose-related increase in Raw in 10-wkold mice (Fig. 4A) , and repeated-measures ANOVA indicated that changes in Raw were significantly greater (P Ͻ 0.001) in Cpe fat compared with wild-type mice. There was no significant difference in baseline G and H between 10-wk-old Cpe fat and their age-matched controls, although there was a trend for both to be increased in the Cpe fat mice (Fig. 4, B and C) . Further- Fig. 1 . Total body masses of male and female wild-type and Cpe fat mice at 7 or 10 wk of age. Values are means Ϯ standard error of the means (SE); n ϭ 6Ϫ16 mice for each group. *P Ͻ 0.05 compared with age-and sex-matched, wild-type mice. Fig. 2 . Serum concentrations of soluble tumor necrosis factor receptor 1 (sTNFR1) (A), sTNFR2 (B), IL-6 (C), monocyte chemotactic protein (MCP)-1 (D), leptin (E), and adiponectin (F), as well as the number of blood leukocytes (G) from room airexposed wild-type and Cpe fat mice, which are 7 or 10 wk of age. Values are means Ϯ SE; n ϭ 6Ϫ9 mice for each group. *P Ͻ 0.05 compared with age-matched, wild-type mice. more, methacholine did not significantly increase G or H, in either 10-wk-old Cpe fat or wild-type mice (Fig. 4, B and C) . O 3 -induced lung injury and inflammation. We have previously reported that the lung injury and inflammation induced by acute O 3 exposure are significantly greater in Cpe fat vs. wild-type mice that are at least 14 wk of age (25) . To examine the onset of this phenomenon with increasing obesity, we measured the concentrations of BALF protein, IL-6, KC, MIP-2, and eotaxin as well as the number of macrophages, neutrophils, and epithelial cells in the lavage fluid of 7-and 10-wk-old wild-type and Cpe fat mice (Fig. 5 ). Exposure to O 3 increased BALF protein, IL-6, KC, MIP-2, eotaxin, neutrophils, and epithelial cells. Factorial ANOVA indicated a significant interaction between genotype and exposure on BALF protein, IL-6, KC, MIP-2, neutrophils, and epithelial cells (p Ͻ 0.05 in each case): when considered without regard to age, the response to O 3 was greater in Cpe fat vs. wild-type mice for each of these outcome indicators, consistent with previously reported data from mice at least 14 wk of age (25) . Follow-up analysis using Fisher's least significance difference yielded essentially similar results when each age group was considered separately (Fig. 5) . Indeed, there was no significant interaction between age and genotype for any BALF parameter. We did observe a significant (P Ͻ 0.05) interaction between age and exposure for BALF IL-6, macrophages, neutrophils, and epithelial cells, but not for BALF protein, KC, MIP-2, or eotaxin: when considered without regard to genotype, BALF macrophages, neutrophils, and epithelial cells were lower in O 3 -exposed, 10-wk-old compared with 7-wk-old mice, while BALF IL-6 was higher. Follow-up analysis using Fisher's least significance difference yielded essentially similar results when each genotype was considered separately (Fig. 5) . Note that the number of BALF macrophages was reduced rather than increased by ozone (Fig. 5) , which likely reflects their increased activation and adhesion, making them less easy to wash out of the lungs. Furthermore, lymphocytes and eosinophils were virtually absent in the BALF of both wild-type and Cpe fat mice, regardless of exposure (data not shown).
DISCUSSION
Our results demonstrate that small increases in body weight (i.e., 25%) were sufficient to augment O 3 -induced pulmonary injury and inflammation in 7-wk-old Cpe fat compared with age-matched, wild-type mice, whereas greater increases in body mass (i.e., 61%) were necessary before innate AHR was manifest in Cpe fat mice at 10 wk of age. Augmented responses to O 3 were observed in Cpe fat mice when only the serum levels of leptin, a satiety hormone and proinflammatory cytokine, were elevated, whereas innate AHR was not observed until numerous markers of systemic inflammation (i.e., sTNFR1, sTNFR2, IL-6, leptin, and blood leukocytes) were increased. Consequently, our data suggest that the mechanistic basis for these phenomena are not the same and may develop according to the nature and degree of the chronic systemic inflammation that is present.
In this study, we monitored the onset of obesity in Cpe fat mice from 7 until 10 wk of age (Fig. 1) . Cpe fat mice become obese due to a missense mutation in the gene encoding carboxypeptidase E, an enzyme important in processing prohormones and proneuropeptides involved in satiety and energy expenditure (33) . Obesity develops more slowly in Cpe fat mice than in ob/ob and db/db mice, which are obese due to a genetic deficiency in either leptin or the long isoform of the leptin receptor, respectively (33) . At 8 -12 wk of age, ob/ob and db/db mice weigh ϳ150% more than their lean, wild-type controls (36, 50) , suggesting that leptin is of greater importance in regulating body mass than carboxypeptidase E. Nevertheless, in Cpe fat mice, obesity can be quite marked: mice 14 wk of age and older weighed 88% more than age-matched controls (25) . However, the less rapidly developing obesity observed in Cpe fat mice make this strain a better model of obesity for examining pulmonary changes during the onset of obesity.
Other investigators have examined age-related differences in airway responsiveness to intravenous methacholine in naive mice and report that airway responsiveness is greatest in young (3-4 wk of age) mice and then declines in mice 6 and 8 wk of age (4) . Our data indicate that at 7 wk of age, wild-type and Cpe fat mice have similar responsiveness (Fig. 3A) , but at 10 wk of age, airway responsiveness increases in the Cpe fat mice (Fig.  3B ). This innate AHR is also observed in 14-to 16-wk-old Cpe fat mice (25) and in other types of obese mice (24, 36, 50) . Anesthetics can either increase or decrease responsiveness to bronchoconstrictors (9, 29) , so we cannot rule out the possibility that effects of excess adipose tissue on the absorption, distribution, and metabolism of the anesthetics might be impacting responsiveness in the obese mice. However, the data Values are means Ϯ SE; n ϭ 7Ϫ9 mice for each group. *P Ͻ 0.05 compared with age-and genotype-matched, room air-exposed mice. #P Ͻ 0.05 compared with age-matched, wild-type mice exposed to O3. from 10-wk-old mice indicate that the locus of this innate AHR is the airways rather than the lung tissues, consistent with our previous findings in obese mice (24, 25, 45) . It would be surprising if alterations in the pharmacokinetic profile of the anesthetics differentially impacted the airways and the lung tissues.
Small increases in body mass, such as those observed in the 7-wk-old mice, were not sufficient to evoke AHR (Fig. 3A) . Aside from increases in serum leptin, we also did not observe any significant increases in measures of systemic inflammation in the 7-wk-old Cpe fat mice, whereas most of those outcomes were increased by 10 wk of age (Fig. 2) , when AHR was observed (Fig. 3) . Taken together, the results indicate that the onset of innate AHR correlates temporally with the onset of systemic inflammation in these obese mice, suggesting that this inflammation may contribute to obesity-related AHR. We do not think that changes in serum leptin play a role in this hyperresponsiveness: leptin was already elevated at 7 wk of age in Cpe fat mice, but these mice did not exhibit AHR. Furthermore, exogenous administration of leptin does not augment airway responsiveness to methacholine in unexposed C57BL/6 mice (26), nor does leptin augment contraction of isolated, airway smooth muscle in tissue baths (41) . The soluble forms of the two TNF-␣ receptors, TNFR1 and TNFR2, were also elevated in the serum of 10-wk-old Cpe fat mice (Fig. 2, A and B) . These receptors are cleaved from the cell surface by TNF-␣ converting enzyme, an enzyme that has been shown to be activated under conditions of oxidative stress (17) . Thus it is conceivable that obesity-related elevations in serum sTNFR1 and sTNFR2 are markers of the systemic oxidative stress that is characteristic of obesity (15) . The relationship between oxidative stress and AHR in obesity remains to be established, but it is important to note that obese asthmatics have elevated levels of 8-isoprostane, a marker of oxidative stress, in exhaled breath condensate (31) . We also observed increased levels of the pleiotropic cytokine, IL-6, in the serum of 10-but not 7-wk-old mice (Fig. 2C) . We previously reported increased serum IL-6 in 24-wk-old Cpe fat vs. wild-type mice (49) . While it is conceivable that this increased serum IL-6 contributes to the innate AHR observed in obese Cpe fat mice, others have reported that transgenic overexpression of IL-6 in the lungs of mice decreases rather than increases responsiveness to methacholine (12) . We were surprised to find elevated rather than reduced levels of adiponectin in the blood of 10-wk-old Cpe fat vs. wild-type mice (Fig. 2F) , since we and others have previously observed reduced adiponectin expression in obese mice (19, 36) . Similarly, we have observed reduced adiponectin in Cpe fat mice, which are 25 wk of age and older (unpublished observations). Others have reported similar findings in obese ob/ob mice: younger (8 wk old) ob/ob mice, which are still substantially obese, have increased adiponectin vs. wild-type controls, whereas older (12 wk old) ob/ob mice have reduced adiponectin (61) . One possible explanation is that during initial expansion of adipose tissue, serum adiponectin increases as a result of an increase in adipose tissue mass, whereas with continuing obesity, endoplasmic reticulum stress and other factors act to decrease the ability of individual adipocytes to express adiponectin. When increased by exogenous administration, adiponectin reduces airway responsiveness in allergen-sensitized and -challenged mice, but not in allergen-sensitized, PBS-challenged mice (51) . Taken together, the results suggest that changes in serum adiponectin are unlikely to account for the obesity-related increases in airway responsiveness. There were also substantial, albeit not quite significant increases in serum MCP-1 in the 10-wk-old Cpe fat mice (Fig. 2D) . The relationship between serum MCP-1 and AHR has not been established, but others have reported that the intratracheal administration of recombinant murine MCP-1 to CBA/J mice increases responsiveness to methacholine (8) . Furthermore, dramatic increases in adipose tissue MCP-1 mRNA expression in mice with diet-induced obesity also correspond with the onset of insulin resistance (62) . Finally, there may be other unmeasured aspects of this systemic inflammation that contribute to AHR in obese mice. For example, TNF-␣ is increased in the serum of obese mice (18) , and exogenous TNF-␣ can augment airway responsiveness (55).
We do not know exactly how systemic inflammation might contribute to the induction of AHR in obese mice. It is conceivable that inflammatory moieties in the serum act on airway smooth muscle cells to increase their contractility. However, it is also possible that neurons that innervate the airways or blood vessels that pass close to the airway walls are the target of these inflammatory moieties and that alterations in these cells impact their modulatory effects on airway narrowing.
Compared with age-matched controls, both 7-and 10-wkold Cpe fat mice had increased O 3 -induced pulmonary injury and inflammation compared with wild-type mice, as indicated by increased levels of BALF protein, IL-6, KC, MIP-2, eotaxin, neutrophils, and epithelial cells (Fig. 5) . Similar results were obtained in Cpe fat mice that were 14 wk of age and older (25) , and in other types of obese mice (24, 32, 36, 50, 52) . Since the 7-wk-old mice weighed only 25% more than wildtype controls, these results indicate that even small increases in body mass are sufficient to augment the effects of acute O 3 exposure. For comparison, depending on exactly what BMI one uses as a reference "normal", a 25% increase in body weight in a human subject would place that subject just into the "overweight" range. The results also reveal discordance between the onset of innate AHR and enhanced responses to O 3 exposure in obese mice: whereas 7-wk-old Cpe fat mice had not yet developed innate AHR (Fig. 3A) , increased responses to O 3 were already manifest in these mice (Fig. 5) . Of the various markers of systemic inflammation measured, only serum leptin was significantly elevated in 7-wk-old Cpe fat mice (Fig. 2E) . It is certainly possible that there were other unmeasured aspects of this systemic inflammation that were also increased in the 7-wk-old Cpe fat mice that account for the increased responses to O 3 in these mice. However, elevations in leptin could also account for these observations. In addition to being a satiety hormone, leptin is also proinflammatory (35) . Importantly, we have reported that an intraperitoneal bolus administration of exogenous leptin to wild-type mice before and again just after exposure to 2 ppm O 3 increased BALF IL-6, KC, and protein compared with mice that received intraperitoneal PBS (50) . Interestingly, in that study, the magnitude of the change in serum leptin we induced with leptin treatment was very similar to the magnitude of the increase in leptin observed in 7-wk-old Cpe fat vs. wild-type mice (Fig. 2E) . Both macrophages and airway epithelial cells express leptin receptors (35, 56) Although the goal of this study was not to examine the impact of age on responses to O 3 , we did observe age-related differences in the cellular inflammation associated with O 3 exposure: BALF macrophages, neutrophils, and epithelial cells were lower in 10-than in 7-wk-old mice, whereas, with the exception of BALF IL-6, O 3 -induced changes in other aspects of the inflammatory response to O 3 were largely unaffected by age (Fig. 5) . Others, including ourselves, have reported greater responses to O 3 in adult mice than in neonates (21, 48, 58) , although the impact of age can be modified by mouse strain (58) . However, none of these studies compared 7-and 10-wkold mice. Importantly, in this study, the effect of age was similar in wild-type and in Cpe fat mice. In addition to obesity, Cpe fat mice display many common obesity-related comorbidities, including hyperglycemia, hypertriglyceridemia, and hypercholesterolemia (11, 40, 42, 43) . These conditions could contribute to the onset of obesityinduced asthma. For example, statins, which reduce the levels of cholesterol in the blood, have been shown to reduce allergen-induced airway inflammation in mice (30, 38) . In contrast, we have established that reducing fasting blood glucose by metformin treatment fails to ameliorate the innate AHR or increased responses to O 3 observed in db/db mice (52), suggesting that hyperglycemia is not involved.
In conclusion, our results indicate that an approximate 25% increase in body mass was sufficient to augment O 3 -induced pulmonary injury and inflammation in Cpe fat mice. These results suggest that even small increases in body weight in human subjects may increase their susceptibility to the toxic effects of O 3 . In contrast, greater increases in body mass (i.e., 61%) were necessary before the innate AHR characteristic of obese mice was manifest. The results suggest that the mechanistic bases for the innate AHR and the increased pulmonary responses to O 3 common to murine obesity are different.
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